| December 30, 2005 |
December 30, 2005
Cerus Submits CE Mark Application for European Approval of the Intercept Blood System for Plasma
|
| December 30, 2005 |
December 30, 2005
Cerus Submits IND Application for CRS-100 to FDA
|
| November 2, 2005 |
November 2, 2005
Cerus Corporation Announces Third Quarter Results; Decision to Reenter Phase I Clinical Trial on Red Blood Cell Program
|
| October 13, 2005 |
October 13, 2005
Cerus Corporation to Present at the Rodman & Renshaw Conference
|
| October 11, 2005 |
October 11, 2005
Cerus Corporation to Webcast Third Quarter Financial Results Conference Call
|
| October 5, 2005 |
October 5, 2005
The University of New Mexico and Cerus Receive $23 Million to Develop Tularemia Vaccine
|
| August 2, 2005 |
August 2, 2005
Cerus Corporation Announces Second Quarter Results
|
| July 26, 2005 |
July 26, 2005
Cerus Corporation to Webcast Second Quarter Financial Results Conference Call
|
| July 25, 2005 |
July 25, 2005
Cerus Corporation Announces Publication in Nature Medicine; Killed But Metabolically Active Microbes -- A New Class of Vaccines
|
| July 19, 2005 |
July 19, 2005
Cerus Corporation Appoints Dr. Joseph Eiden Vice President, Clinical Research and Medical Affairs
|
| June 6, 2005 |
June 6, 2005
Cerus and BioOne Enter Agreement for Commercialization of INTERCEPT Plasma; BioOne to Market Pathogen Inactivation for Both Platelets and Plasma in Asian Region
|
| May 5, 2005 |
May 5, 2005
Cerus Corporation to Present at the Fourth Annual Needham Biotechnology Conference
|
| May 3, 2005 |
May 3, 2005
Cerus Corporation Announces First Quarter Financial Results
|
| April 21, 2005 |
April 21, 2005
Cerus Corporation to Webcast First Quarter Financial Results Conference Call
|
| April 19, 2005 |
April 19, 2005
Cerus to Present at American Association for Cancer Research Annual Meeting; Preclinical Safety and Efficacy Data Support Use of Proprietary Listeria Platform for Cancer Immunotherapy
|
| February 5, 2005 |
February 5, 2005
Baxter and Cerus Sign New Agreement to Commercialize INTERCEPT Blood System
|
| February 3, 2005 |
February 3, 2005
Cerus Corporation Announces Fourth Quarter and Year-End Results
|
| January 19, 2005 |
January 19, 2005
Cerus Corporation to Webcast Fourth Quarter and Year-End Financial Results Conference Call
|
| January 5, 2005 |
January 5, 2005
Cerus and BioOne Sign Letter of Intent for Commercialization of INTERCEPT Plasma in Asian Region
|